IL100535A - Pharmaceutical preparations containing a history of xanthine to relieve disease states - Google Patents

Pharmaceutical preparations containing a history of xanthine to relieve disease states

Info

Publication number
IL100535A
IL100535A IL10053587A IL10053587A IL100535A IL 100535 A IL100535 A IL 100535A IL 10053587 A IL10053587 A IL 10053587A IL 10053587 A IL10053587 A IL 10053587A IL 100535 A IL100535 A IL 100535A
Authority
IL
Israel
Prior art keywords
formula
group
compounds
compound
acid
Prior art date
Application number
IL10053587A
Other languages
English (en)
Hebrew (he)
Original Assignee
Hoechst Roussel Pharma
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma, Univ Virginia filed Critical Hoechst Roussel Pharma
Publication of IL100535A publication Critical patent/IL100535A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10053587A 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine to relieve disease states IL100535A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94790586A 1986-12-31 1986-12-31

Publications (1)

Publication Number Publication Date
IL100535A true IL100535A (en) 1994-05-30

Family

ID=25486973

Family Applications (7)

Application Number Title Priority Date Filing Date
IL10053387A IL100533A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states
IL10685487A IL106854A (en) 1986-12-31 1987-12-23 Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard
IL10053587A IL100535A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine to relieve disease states
IL10685987A IL106859A (en) 1986-12-31 1987-12-23 Pentoxifilin metabolites and pharmaceutical preparations containing them for the treatment of VIH and similar diseases
IL10053687A IL100536A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine Stopping an immune response and relieving adverse conditions resulting from intracellular intervention in an immune response
IL8493487A IL84934A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines
IL10686187A IL106861A (en) 1986-12-31 1987-12-23 Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL10053387A IL100533A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states
IL10685487A IL106854A (en) 1986-12-31 1987-12-23 Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard

Family Applications After (4)

Application Number Title Priority Date Filing Date
IL10685987A IL106859A (en) 1986-12-31 1987-12-23 Pentoxifilin metabolites and pharmaceutical preparations containing them for the treatment of VIH and similar diseases
IL10053687A IL100536A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine Stopping an immune response and relieving adverse conditions resulting from intracellular intervention in an immune response
IL8493487A IL84934A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines
IL10686187A IL106861A (en) 1986-12-31 1987-12-23 Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines

Country Status (14)

Country Link
EP (1) EP0279079B1 (da)
JP (1) JP2507012B2 (da)
KR (1) KR960015726B1 (da)
AT (1) ATE151290T1 (da)
AU (1) AU668982B2 (da)
CA (1) CA1313137C (da)
DE (1) DE3752048T2 (da)
DK (1) DK482088A (da)
ES (1) ES2103255T3 (da)
GR (1) GR3024054T3 (da)
IE (1) IE873554L (da)
IL (7) IL100533A (da)
WO (1) WO1988004928A1 (da)
ZA (1) ZA879754B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
AU5921890A (en) * 1989-06-13 1991-01-08 Smithkline Beecham Corporation Monokine activity interference
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
IL100195A0 (en) * 1990-11-30 1992-08-18 Hoechst Roussel Pharma Use of xanthines for the preparation of a medicament having immuno suppressing activity
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
EP0493682A3 (en) * 1990-11-30 1992-11-19 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
AU664189B2 (en) * 1991-05-24 1995-11-09 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
JPH05194233A (ja) * 1991-06-10 1993-08-03 Hoechst Roussel Pharmaceut Inc マイクロペレットおよびそれらの製造方法
WO1993003728A1 (en) * 1991-08-27 1993-03-04 Temple University Of The Commonwealth System Of Xanthine suppression of antigen activation of t- or b-cells
WO1993008820A1 (en) * 1991-10-31 1993-05-13 The Victoria University Of Manchester Treatment of neurological conditions by an interleukin-1 inhibiting compound
AU3539795A (en) * 1994-08-25 1996-03-14 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
JP3830115B2 (ja) * 1997-10-06 2006-10-04 シャープ株式会社 液晶表示素子
TW561297B (en) * 1997-11-25 2003-11-11 Toshiba Corp Electrode wiring board subjected to counter measure against static electricity and display device using the same
JP3019053B2 (ja) * 1997-12-25 2000-03-13 日本電気株式会社 液晶表示装置及びその製造方法
MX2010009300A (es) 2008-02-29 2010-11-05 Concert Pharmaceuticals Inc Derivados de xantina substituidos.
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
EP2473052A4 (en) 2009-09-02 2013-03-20 Concert Pharmaceuticals Inc SUBSTITUTED XANTHINE DERIVATIVES
WO2012031138A2 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
US20140296263A1 (en) 2011-07-19 2014-10-02 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
MX2014012384A (es) 2012-04-13 2014-11-26 Concert Pharmaceuticals Inc Derivados sustituidos de xantina.
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005015B1 (en) * 1978-04-22 1986-10-29 BEECHAM - WUELFING GmbH & Co. KG Use of a xanthine derivate in the manufacture of a medicament
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment

Also Published As

Publication number Publication date
AU637542B2 (en) 1993-05-27
IL100536A (en) 1994-05-30
GR3024054T3 (en) 1997-10-31
ES2103255T3 (es) 1997-09-16
DE3752048D1 (de) 1997-05-15
AU1150588A (en) 1988-07-27
AU1291892A (en) 1992-05-14
ZA879754B (en) 1989-07-26
ATE151290T1 (de) 1997-04-15
KR890700347A (ko) 1989-04-24
JP2507012B2 (ja) 1996-06-12
KR960015726B1 (ko) 1996-11-20
WO1988004928A1 (en) 1988-07-14
IL84934A (en) 1994-08-26
CA1313137C (en) 1993-01-26
EP0279079B1 (en) 1997-04-09
DK482088A (da) 1988-10-28
DK482088D0 (da) 1988-08-30
AU668982B2 (en) 1996-05-23
IE873554L (en) 1988-06-30
EP0279079A3 (en) 1990-06-13
DE3752048T2 (de) 1997-10-02
AU619732B2 (en) 1992-02-06
IL106859A (en) 1996-10-16
EP0279079A2 (en) 1988-08-24
IL106861A (en) 1997-02-18
IL106854A (en) 1996-05-14
AU4602793A (en) 1993-11-18
JPH02501829A (ja) 1990-06-21
IL100533A (en) 1994-05-30

Similar Documents

Publication Publication Date Title
IL100535A (en) Pharmaceutical preparations containing a history of xanthine to relieve disease states
US5096906A (en) Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) Method of inhibiting the activity of leukocyte derived cytokines
US5464781A (en) Amino naphthyridine compounds as anti-rhoumatic agents
EP0011609B2 (en) Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease
JPH05506436A (ja) 冠状血管拡張剤および抗高血圧症剤としての２―アラルコキシおよび２―アルコキシアデノシン誘導体類
EP0304221B1 (en) 5-amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents
IL35658A (en) 2, 6 - Diamino - 9 -) B - D - Arbinopuranosil (- Purine, its preparation and use in pharmacy
CN1990470B (zh) 酞丁安衍生物及其制法和其药物组合物与用途
HUT59825A (en) Process for producing immuno-inhibiting pharmaceutical compositions containijng xantine derivatives
CN112479974B (zh) 一种3-羰基-2,3’-联吲哚氮氧化物衍生物的制备和应用
JPS6157584A (ja) 抗ウイルス化合物
CN116217621B (zh) 一种核苷类双前药、合成方法及应用
CA2173116C (en) Ring-expanded nucleosides and nucleotides
CN115636809B (zh) 一种查尔酮类衍生物的合成及其制药应用
US5196430A (en) Method of inhibiting the activity of leukocyte derived cytokines
AU619732C (en) Method of inhibiting interleukin-1 activity
US5196429A (en) Method of inhibiting the activity of leukocyte derived cytokines
CN112625010B (zh) 一种9-羟基菲醌衍生物及其制备方法和应用
JP3273108B2 (ja) 新規ピリド〔２，３−ｄ〕ピリミジン誘導体及びその製造方法
WO2005095376A1 (en) Antiviral agents
EP0070477A1 (en) Novel ester of 6-((hexahydro-1H-azepin-1-yl)methyleneamino)penicillanic acid, process for its production, and its use as antibacterial agent
JPH0356417A (ja) 抗転移剤として有用な５―アミノ又は置換アミノ１，２，３―トリアゾール類
CN116925080A (zh) 作为Akt蛋白激酶抑制剂的化合物及其制备方法和用途
NZ232452A (en) 6-amino-9h-purin-9-yl and 2-amino-6-hydroxy-9h-purin-9-yl dideoxy nucleoside derivatives; intermediates and pharmaceutical compositions

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees